-
Da Vinci Robotic-Assisted Surgery: 5 years of Health Technology Assessment Trends and Recommendations
Mar 10, 2025, 14:00 PM -
Understanding Racial Differences in Emergency Room Visits for Patients with Lupus
Mar 10, 2025, 14:00 PM -
Impact of NGS Testing Timing on Real-World Treatment Patterns and Clinical Outcomes in Colorectal Cancer: A Retrospective Observational Study
Mar 10, 2025, 14:00 PM -
Gut Microbiota and Inflammation in Patients Which Schizophrenia
Mar 10, 2025, 14:00 PM -
Estimated Impact of the Inflation Reduction Act on Out-of-Pocket Spend Among Medicare Part D Beneficiaries with Cancer
Mar 10, 2025, 14:00 PM -
Modeling Challenges and Critiques in Economic Evaluations of Medical Devices: A Review of NICE Medical Technologies Guidance
Mar 10, 2025, 14:00 PM -
Diffusion and Launch Sequencing of Cell and Gene Therapies across the USA, Europe, Canada and Australia
Mar 10, 2025, 14:00 PM -
Integrating Cancer Trials Into Value-Based Care: The ‘Let Me Trial’ Model in Brazil
Mar 10, 2025, 14:00 PM -
Real-World Hereditary Angioedema Attack Rates Before and After Berotralstat Initiation Among Adolescents
Mar 10, 2025, 14:00 PM -
Describing the Amyotrophic Lateral Sclerosis US Population and Use of Supportive Aids and Interventions: Results from a Real-World Survey
Mar 10, 2025, 14:00 PM -
Economic Feasibility of 'Pay One Price': An Analysis of Three Biosimilar Molecules with Different Prices and Indicated for Rheumatoid Arthritis in a Medium Size HMO
Mar 10, 2025, 14:00 PM -
Economic Impact of Implementing a Clinical Protocol and Therapeutic Guidelines for Cow's Milk Protein Allergy in Two States of Brazil
Mar 10, 2025, 14:00 PM -
Risk of Hospital Readmission Among Adults Aged 50 Years and Older Hospitalized With Respiratory Syncytial Virus (RSV) or Influenza
Mar 10, 2025, 14:00 PM -
Measuring Patient- and Carer-Reported Outcomes Following Genome Sequencing for Rare Disease Diagnosis: A Psychometric Assessment of Outcome Measurement Instruments
Mar 10, 2025, 14:00 PM -
2015-2024 Pricing Advantage of First-in-Indication Non-Oncology Orphan Products Versus Late Entrants and Recent Trends
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness Analyses of Repotrectinib in TKI-Naïve Patients with ROS1+ Advanced Non-Small Cell Lung Cancer
Mar 10, 2025, 14:00 PM -
The Role of Real-World Evidence in Addressing Gaps in Health Technology Assessment in Brazil’s Public Healthcare System
Mar 10, 2025, 14:00 PM -
Characterizing Improvements in Physical Functioning with PROMIS-PF and In-Trial Exit Interviews: A Mixed-Methods Analysis to Understand the Meaningful Changes Experienced by TGCT Patients on Vimseltinib in the MOTION Trial
Mar 10, 2025, 14:00 PM -
Patient Voice in Rare Disease Health Technology Assessments: Recent Trends in the Use of Qualitative Research in Reimbursement Submissions to Canada's Drug Agency
Mar 10, 2025, 14:00 PM -
Navigating Evidence Requirements for Joint Clinical Assessment of Orphan and Advanced Therapy Medicinal Products in Europe
Mar 10, 2025, 14:00 PM
